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ABSTRACT
The opioid epidemic has emerged as a public health crisis, attracting increasing
nationwide attention. Electronic health records (EHRs) provide rich resources
to investigate and predict the risk of opioid use disorder (OUD) in real-world
settings due to its diversity of data types and wide range of information. In this
dissertation, I conducted three studies to investigate the association between OUD
and different f actors i n E HR, i ncluding d emographics, c omorbidity, laboratory
test results, medications, and opioid prescription, and develop predictive models
to predict OUD risk using features from EHR data.
In Manuscript 1, we used penalized logistic regression models to predict OUD
in the emergency department in order to handle the large number of predictors
and imbalanced classes for OUD in EHR data. We presented the prediction performance of Lasso logistic regression, Firth logistic regression, Firth logistic regression
with intercept-correction (FLIC), and Firth logistic regression with added covariate (FLAC) and show how physical and mental comorbidity contributed to the
risk of opioid misuse in the emergency department.
In Manuscript 2, a shared parameter joint model for longitudinal and timeto-event data was built to investigate the association between longitudinal opioid
prescription dosages and time to OUD onset after patients’ first opioid prescription
from emergency department. Results from the models suggested a weak positive
association between longitudinal opioid prescription dosage and the OUD onset.
We also tested how the shared parameter model can handle data missing at random
in a simulation study shown in Appendix B.
In Manuscript 3, we proposed a conditional Gated Recurrent Unit with decay
rate (GRU-D) model to predict the risk of opioid dependence and abuse using
both static features, like demographics and disease history, and temporal features,

such as laboratory test results during the entire visit. The GRU-D model allows
us to capture the patterns of temporal features even though the measurements in
EHR are collected irregularly or missing due to practical issues. We presented and
discussed the predictive performance of our proposed conditional GRU-D with a
GRU-D model with only temporal features and a GRU-D model with static features added at first time step. In addition, we investigated the feature importance
using Leave-One-Covariate-Out (LOCO) approach. The top 15 most important
predictors was presented, covering static features, such as insurance type, race,
anxiety history, and also temporal features, such as blood test results, and medication use.
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MANUSCRIPT 1
Evaluating Risk of Opioid Use Disorder in Electronic Health Records
using Penalized Logistic Regression
1.1

Introduction
Over the past two decades, the opioid epidemic has emerged as a public health

crisis, attracting increasing nationwide attention. In 2019, over 10 million Americans reported misuse of prescription opioids (SAMHSA, 2020), and opioid overdose related deaths have increased from less than 10,000 in 1999 to about 50,000
(Mattson et al., 2021; NIDA, 2021). What’s worse, the COVID-19 pandemic has
sped up the increase in drug overdose deaths. Throughout the 12-month period
ending in May 2020, opioid overdoses killed around five times more people than
in the 12 months of 1999 (CDC and NCHS, 2020), which caused an overwhelming
economic burden on national health care. A major contributing cause of opioid
overdose and deaths in the United States is opioid use disorder (OUD).
The development of Opioid Use Disorder (OUD) results from various risk
factors. Psychiatric disorders are associated with a greater risk of opioid use disorder. A national wide study using 2017 and 2018 National Survey on Drug Use and
Health suggested that psychological distress was one of the significant predictors of
OUD (Montiel Ishino et al., 2020). Edlund et al.(Edlund et al., 2007) also found
that a history of mental health diagnosis was a moderate predictor of opioid misuse among veterans with chronic pain. Major depressive episode experience was
also identified as one of the strongest predictors for adolescent opioid misuse in
Han et al.’s machine learning models (Han et al., 2020). Another important risk
factor for OUD is the personal history of illicit substance use (Turk et al., 2008;
Webster, 2017; Han et al., 2020). Turk et al. reviewed multiple articles that address predictors for opioid abuse among chronic pain patients and concluded that
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a history of non-opioid substance abuse is one of the most consistent predictors for
opioid misuse (Turk et al., 2008).
Besides psychiatric disorders, previous studies on predicting opioid misuse
have unraveled the importance of physical health conditions in the development of
OUD (Webster, 2017; Ciesielski et al., 2016; Michna et al., 2004; Ives et al., 2006;
Katz et al., 2013; Bilal et al., 2019). Katz et al. examined the relationship between opioid abuse and physical conditions using a population-based national
sample and found that the increasing number of physical conditions, such as arteriosclerosis or hypertension, cardiovascular disease, arthritis, and any assessed
medical condition, are significant risk factors for opioid abuse after controlling for
social factors and mental disorders (Katz et al., 2013). In addition, hypertension,
hyperlipidemia, and heart failure also persisted as notable predictors for OUD in
machine learning models (Segal et al., 2020; Lo-Ciganic et al., 2020). Bilal et al.
(Bilal et al., 2019) also showed that the more severe the disease, the higher the
risk of OUD.
In addition, the wide sites of opioid receptors across human tissues and organ systems, including vital centers in the brain, distinguish opioids from other
substances of abuse. It was shown that OUD may affect neuroendocrine functioning and immune response, which increases the risk of complications and infections, as well as the mortality of overdose (Brick, 2012). Bogdanowicz et al.
also found that individuals with OUD who also have co-occurring Personality
Disorder or Alcohol Use Disorder have an elevated risk of all-cause mortality
(Bogdanowicz et al., 2015). Therefore, it is critical to better describe the patterns of comorbidity between mental/physical illness and OUD in clinical practice
to assist doctors in treatment strategies and medication management, thereby optimizing treatment outcomes and decreasing mortality.
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Large scale de-identified Electronic Health Records provide a great resource
for investigating the risk factors related to OUD in a complex real-world healthcare
environment, which includes demographic information, diagnoses, laboratory test
results, vital signs, prescriptions, and procedures data. In the past decade, EHR
data have been increasingly used to develop predictive models to support decision
making, including predicting in-hospital mortality (Rajkomar et al., 2018), the intensive care readmission (Rojas et al., 2018), and suicide risks (Su et al., 2020).
In the current study, we consider the logistic regression model for binary outcome
classification considering its interpretability.
However, the enormous number of available variables also poses challenges
for classification prediction. First of all, if the sample size is limited and the
number of predictors is large, logistic regression carries with it a higher risk for
model overfitting. This model memorizes too many details or even noises in the
training cases, which thus can potentially lead to low accuracy when evaluated
on unseen cases (Dreiseitl and Ohno-Machado, 2002). Furthermore, in real-world
non-specialty medical settings, the prevalence of OUD may be very small. A
3-year observational study in six health systems indicates the OUD prevalence
among primary care patients was only 1.0% (Lapham et al., 2020). The National
Emergency Department Sample (NEDS) dataset, which is the largest all-payer ED
database in the United States, consists of approximately 234 million adults who
visited an ED in 2016 and 2017. Among all the ED visits, only 1.23% were related
to opioids (Langabeer et al., 2021). In Rhode Island, where the data for this study
were collected, only 298.3 per 100,000 population of ED visits were opioid-related
(Weiss et al., 2017). This case is called imbalanced data, which means one class
has many more samples than the rest of the classes. The classification models aim
to minimize the percentage of incorrectly predicted classes in the training process.
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They can achieve reliable results when the sample sizes of all categories are equal
or close. But when a data set is imbalanced, the classification model may have very
high accuracy for the majority class but extremely low accuracy for the minority
class. Especially, when the data set is unbalanced and the feature dimension is
large, the maximum likelihood estimation (MLE) of logistic regression can lead to
biased or infinite estimates of coefficients or convergence failure due to complete
separation (Rahman and Sultana, 2017; Box, 1971; Abdullah et al., 2019).
Various methods to handle high dimensional predictors and imbalanced data
have emerged in recent years. The least absolute shrinkage and selection operator
(Lasso) (Tibshirani, 1996) can achieve variable selection and parameter estimation
through L1 -norm penalty. It can set the coefficients of certain predictors to zero in
order to select only meaningful predictors from a large list of predictors. In a similar
manner, Firth logistic regression employs the square root of the determinant of the
Fisher Information Matrix as the penalty to remove the first order bias of MLE and
obtain accurate and finite estimates (Firth, 1993). Moreover, two modifications
of Firth logistic regression were suggested to prevent overestimation of predicted
probabilities in the case of imbalanced data (Puhr et al., 2017). First, the Firth
logistic regression with intercept-correction (FLIC) considers a simple post hoc
adjustment of the intercept to get accurate estimation for better predictions. The
second method, Firth logistic regression with added covariate (FLAC), utilizes
a ghost factor as an added covariate to distinguish between original and pseudo
data. On the augmented data, the MLE may be deployed to re-calibrate the
average predicted probability to the ratio of events in the original data.
The purpose of this study is to illustrate the use of penalized logistic regression
in detecting OUD in the emergency department. In particular, we would like to
compare the prediction performance of several different penalized logistic regression
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models, including Lasso, Firth, FLIC, and FLAC. Furthermore, we investigate the
significant predictors of OUD and the patterns of comorbidity obtained from these
models.
1.2 Methodology
1.2.1 Research Design and Data Source
The current study is a prognostic study with a retrospective cohort design.
231 adult patients’ electronic medical records were extracted from the EHR system
at Roger Williams Medical Center between February and July of 2020. The dataset
includes patients’ demographics, physical conditions at admission, and comorbidity. The patient’s OUD diagnosis was detected using ICD-10 codes (dsm, 2017),
including F11.10 (Opioid Use Disorder, Mild), F11.11 (Opioid Use Disorder, Mild,
in early or sustained remission), F11.20 (Opioid Use Disorder, Moderate, F11.21
(Opioid Use Disorder, Moderate, in early or sustained remission), F11.20 (Opioid
Use Disorder, Severe), and F11.21 (Opioid Use Disorder, Severe, in early or sustained remission). Patients with one or more of these codes were considered OUD
patients. The dataset consists of 14 patients with OUD diagnosis.
1.2.2

Study Variables

The demographics of subjects such as age, gender, race, ethnicity, body mass
index (BMI), and type of insurance were included as predictors. In addition, we
also consider some measurement of subjects’ pgysiologic conditions, such as their
Glasgow Coma Score (GCS) at admission, time on mechanical ventilation, length
of stay in the intensive care unit (ICU). The top 30 of most frequent diseases were
identified based on patients’ comorbidity ICD-10 codes as listed in Table 1, and
included in the penalized logistic regression models. The continuous variables were
standardized before included in the model.
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1.2.3

Statistical Analysis

The data analysis and modeling were performed using R programming language (R Core Team, 2018). The data were first check and cleaned for outliers.
Missing values were only found in the variable BMI, and were imputed with the
mean of other observed values. The preliminary analysis included descriptive
statistics such as frequency, mean and correlation to assess the distribution of
the data.
1.2.4

Penalized logistic regression model

In binary logistic regression, a single outcome yi (i = 1, · · · , n) follows a
Bernoulli probability function that takes either 1 with probability πi or 0 with
probability 1 − πi . The probability function can be presented through a linear
function of the predictors xi = (1, xi1 , · · · , xip ):
P (yi = 1|xi ) = πi = [1 + exp(−xTi β)]−1 ,
where β = (β0 , β1 , · · · , βp )T includes the intercept β0 and the unknown coefficients
of the p predictors we want to estimate. The MLE gives the estimate for β by
maximizing the log-likelihood function:
l(β) =

n
X

[yi log(πi ) + (1 − yi ) log(1 − πi )].

i=1

The idea of penalized regression is to modify the log-likelihood function by adding
a penalty function as a size constraint on the coefficients (Hastie et al., 2009). In
this study, we used Lasso penalty function and Firth’s penalty function.
Lasso
To handle high dimensional predictors, Lasso logistic regression considers a
L1 norm penalty function (Tibshirani, 1996). Thus, the log-likelihood function
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becomes:
lLasso (β) = l(β) − λ

p
X

|βj |,

j=1

where λ is a tuning parameter. We can use 10-fold cross validation to get the
optimal λ that minimizes the log-likelihood function across all 10 partitions. Lasso
logistic regression gives a sparse model where some coefficients are forced to be 0.
This enables us to perform automatic variable selection and parameter estimation
simultaneously, and also reduce the risk of overfitting.
Firth
Firth introduced the Jeffreys invariant prior as a penalty term to remove the
first-order term in the asymptotic bias expansion of MLE (Firth, 1993). The Jefferys invariant prior is the square root of the determinant of the Fisher information
matrix |I(β)|1/2 . The Firth’s penalised log-likelihood function is:
lF irth (β) = l(β) +

1
log(|I(β)|).
2

When β = 0, πi is maximized to 0.5, and thus Firth’s penalty term is maximized.
Therefore, using this penalty term can shrink the coefficients towards 0. We can
use backward elimination to select significant predictors.
However, because the Firth’s penalty gets to its maximum when πi = 0.5, the
effects of this penalty have a tendency to bring the predicted probability closer
to one-half in comparison with MLE (Puhr et al., 2017). Thus, when there is
a minority group in the data, Firth logistic regression is prone to overestimate
predictions. Puhr et al. proposed two modifications of Firth logistic regression to
avoid biased average predicted probabilities.
First, the Firth logistic regression with intercept-correction (FLIC) estimates
the intercept and coefficients following the steps below:
1. Estimate predictors’ coefficients β̂F L by Firth’s penalization, excluding the
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intercept
2. Obtain the MLE of the intercept β̂0 in the logistic regression P (yi = 1) =
(1 + exp(−β0 − xTi β̂F L ))−1 by including β̂F L as an offset
3. So, the FLIC estimate β̂F LIC is then given by Firth’s estimate β̂F L with the
intercept replaced by β̂0 ,β̂F LIC = (β̂0 , β̂F L,1 , · · · , β̂F L,p ).
In the second method, Firth logistic regression with added covariate (FLAC),
a ghost indicator g to discriminate between original and weighted observations
is included as an additional covariate in the model and the model is fitted using
the augmented data (Puhr et al., 2017). The FLAC estimate can be obtained as
follows:
1. Conduct Firth logistic regression and calculate the diagonal elements hi of
1

1

the hat matrix. The hat matrix is W 2 X(X ′ W X)−1 X ′ W 2 , where X is the
design matrix, W is the diagonal matrix of πi (1 − π1 ), and I(β) = X ′ W X
2. Define an augmented data set by combining the original observations,the
original observations weighted by hi /2, and the original observations
weighted by hi /2 but with yi replaced by 1yi
3. Define a ghost indicator g, where g = 0 for original observations, and g = 1
for the other two pseudo data sets
4. Then, we can get FLAC estimate β̂F LAC using MLE on the augmented data
with g as an added covariate.
We implemented the Lasso logistic regression using the R package glmnet (Friedman et al., 2010). We performed 10-fold cross validation to find optimal λ that can minimize the error function.

The Firth logistic regression,

FLIC, and FLAC were implemented using the functions from R package logistf
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(Heinze et al., 2022). Backward elimination was conducted to achieve variable selection in the Firth models. All variables left in the model after this procedure are
considered selected. The data were split into 70% training set and 30% testing set.
The performance of these models in testing set was reported using measures such
as sensitivity, specificity, accuracy, precision, F1-score, Akaike Information Criterion(AIC), area under the receiver-operating characteristic (ROC), and Precision
recall (PR) curves.
1.3 Results
1.3.1 Demographic and medical characteristics
Table 1.1 shows the demographic and medical characteristics of the sample.
Overall, the sample consists of 231 (45.0% female) patients aged 18 to 96 years at
admission (M = 63.38, SD = 16.75). Of the sample, 65.8% (n = 152) were White,
and 77.5% (n = 179) were not Hispanic or Latino. 134 patients were covered
by private insurance, 81 were covered by Medicare or Medicaid, and others were
uninsured or unknown. The mean Glasgow Coma Score (GCS) at admission of
the sample was 7.23 (SD = 6.59). The length of stay in ICU in the sample ranged
from 1 hour to 2116 hours, with an average of 102.35 hours and the average time
on mechanical ventilation of the sample was 48.35 hours. Most of the patients
(70.6%) transfered out of the ICU, 13.4% discharged from the ICU and others
expired inside or outside of the ICU.
The prevalence of any OUD diagnosis in the whole sample was 6.1%. All the
patients had at least one of the 30 physical or mental conditions included in Table
1.1. Of all the patients, 11.7% had 1-10 conditions, 37.2% had 11-20 conditions, and
51.1% had more than 20 conditions. Gastrointestinal disease (64.1%), hypertensive
disease (50.2%), hyperlipidemia (48.1%), Long term use of drug therapy (47.2%)
and chronic pain (42.9%) were more common than others. For each of the 30
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physical or mental conditions, any OUD was more prevalent among those with
some condition than those without it. These conditions include acidosis, other
substance use disorders (cannabis, stimulants, sedatives, hypnotics, and multiple
drug use disorder), and nicotine dependence (ND) or personal history of ND.
Table 1.1: Demographic and medical characteristics

Age at Admission
BMI(kg/m2 )
Glasgow Coma Score (GCS)
at Admission
Time on Mechanical
Ventilation (hours)
Length of Stay in ICU (hours)
Numbers of Comorbidity
Gender
Race

Ethnicity
Hypertensive disease
Acute respiratory failure
Acidosis
Hypothyroidism
Hypokalemia
Acute kidney failure
Hypo-osmolality
and hyponatremia
Hyperkalemia
Type 2 diabetes mellitus

Opioid Use Disorder
No
Yes
64.346
48.357
29.438
28.979
6.963
11.357

Male
Female
White
Non-white/
unavailable
Not Hispanic/Latino
Hispanic/Latino
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No

41.968

147.357

94.650
21.700
119
98
144

221.643
23.643
8
6
8

73
170
47
106
111
144
73
149
68
188
29
149
68
149
68
155
62
184
33
187

6
9
5
9
5
9
5
6
8
12
2
7
7
8
6
9
5
14
0
12
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with renal complications
with other multiple complications Yes
Myocardial infarction type 2
No
Yes
Spesis
No
Yes
Hypomagnesemia
No
Yes
Cardiovascular
No
and ischaemic disease
Yes
Gastrointestinal disease
No
Yes
Hyperlipidemia
No
Yes
Cancer
No
Yes
Chronic pain
No
Yes
Disorders of phosphorus
No
metabolism and phosphatases
Yes
Metabolic encephalopathy
No
Yes
Diseases of musculoskeletal
No
system and connective tissues
Yes
Pneumonia
No
Yes
COPD
No
Yes
Depression
No
Yes
Anxiety Disorder
No
Yes
Other Psychosis
No
or mental disorder
Yes
Alcohol use disorders
No
Yes
Other substance use disorders
No
Yes
Nicotine Dependence (ND)
No
or personal history of ND
Yes
Acute posthemorrhagic
No
anemia and anemia
Yes
Dehydration
No
Yes

30
161
56
152
65
170
47
163
54
74
143
107
110
176
41
123
94
171
46
175
42
167
50
159
58
170
47
187
30
183
34
191
26
191
26
184
33
144
73
151
66
182
35

2
11
3
9
5
10
4
12
2
9
5
13
1
14
0
9
5
10
4
10
4
9
5
10
4
9
5
11
3
12
2
11
3
12
2
3
11
3
11
10
4
11
3
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Long term use of drug therapy
Mortality

Insurance type

No
114
Yes
103
expired
25
discharged
30
transfer out of ICU
152
expired outside of ICU 10
Private
127
medicare/mediaid
75
others/uninsured
15

8
6
2
1
11
0
7
6
1

1.3.2 Penalized Logistic Regression of OUD
Lasso Logistic Regression
We first conducted Lasso logistic regression to identify predictor significantly
correlated with OUD. Through 10-fold cross validation, we selected the value that
minimized the error term as optimal tuning parameter, λ = 0.014. The results
of the final Lasso regression model in Table 1.2 show that OUD was significantly
associated with 13 predictors out of 41 candidate predictors. Patients, who had
higher GCS at admission, was non-white, expired outside of the ICU or had acidosis, acute kidney failure, depression, other substance use disorder, nicotine dependence (ND) or personal history of ND, or dehydration, were more likely to have
any OUD. Other predictors were negatively associated with any OUD, including
age, gastrointestinal disease, hyperlipidemia, and alcohol use disorder. Among
all 13 significant predictors, other substance use disorder (cannabis, stimulants,
sedatives, hypnotics, and multiple drug use disorder) was the most significant predictor, with β = 1.836, OR = 6.269. This suggests patients with other substance
use disorder were 5.269 times more likely to have any OUD than those without.
Firth Logistic Regression
Next, we fitted a Firth logistic regression model with 41 predictors. The
backward elimination algorithms was applied for variable selection. There were
9 variables selected as significant predictors of OUD in the final Firth logistic
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Table 1.2. Coefficients and odds ratio of predictors in Lasso logistic regression
Predictors
Coefficient Odds ratio
Age
-0.642
0.526
GCS
0.268
1.308
Race
0.157
1.170
Acidosis
0.192
1.212
Acute kidney failure
0.011
1.012
Gastrointestinal disease
-0.465
0.628
Hyperlipidemia
-1.523
0.218
Depression
0.163
1.177
Alcohol use disorder
-0.168
0.845
Other substance use disorder 1.836
6.269
Nicotine dependence (ND) or
personal history of ND
0.089
1.093
Dehydration
0.145
1.157
Expired outside of the ICU
1.053
2.867
regression model. Next, the FLIC and FLAC were conducted to with these 9
variables to get unbiased or less biased estimates. Table 1.3 shows the coefficient
estimates with standard errors from three Firth models. Being male, not having
hyperlipidemia, anxiety disorder, or alcohol use disorder, and not being covered by
Medicare/Medicaid were significantly related to having any OUD. A patient with
younger age or shorter time on mechanical ventilation is more likely to have any
OUD. In addition, staying in the ICU for a longer time period, or having nicotine
dependency (ND) or personal history of ND were significantly related to higher
risk of any OUD diagnosis.
The estimates of coefficients were almost same for Firth logistic regression
and FLIC, while FLAC’s estimates were slightly different. Among all three models, FLIC provided coefficient estimates with the smallest standard errors for 9
variables.
The odds ratios with 95% confidence intervals were reported in Table 1.4. The
odds ratios of two positive predictors, length of stay in the ICU(ORF irth,F LIC =
404.171, ORF LAC = 440.647), and ND or personal history of ND (ORF irth,F LIC =
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1386.617, ORF LAC = 1462.239), were large, suggesting a strong association with
OUD. The wide 95% confidence intervals and large odds ratios are due to high
standard deviation in length of stay in the ICU (SD = 219.620), or imbalanced
OUD classes with only 6% positive cases. The imbalanced classes of OUD also
made the odds ratios for negative predictors close to 0 as shown in Table 1.4.
Table 1.3. Coefficients with standard errors (se) in Firth models
Firth
FLIC
FLAC
Age
-4.473
-4.473
-4.551
(1.462)
(1.051)
(1.514)
Gender
-3.968
-3.968
-4.022
(1.715)
(1.331)
(1.769)
Time on Mechanical
-4.540
-4.540
-4.663
Ventilation
(1.549)
(1.306)
(1.611)
Length of Stay in ICU
6.002
6.002
6.088
(1.960)
(1.531)
(2.036)
Hyperlipidemia
-8.781
-8.781
-8.995
(2.775)
(2.301)
(2.873)
Anxiety disorder
-3.961
-3.961
-4.041
(1.651)
(1.073)
(1.685)
Alcohol use disorder
-7.498
-7.498
-7.681
(2.826)
(1.943)
(2.911)
ND or personal history
7.235
7.235
7.288
of ND
(2.269)
(1.342)
(2.323)
Medicare or Medicaid
-3.894
-3.894
-4.068
(1.913)
(1.425)
(1.984)

1.3.3

Model Performance Comparison

We then compared the classification performance of 4 models using testing set.
In Table 1.5, Lasso logistic regression with 13 predictor had the highest accuracy
of 97.1% and the lowest AIC of -19.903. However, in the case of imbalanced data,
accuracy is not the most appropriate measure for prediction performance. Because
the effect of the minority but more meaningful samples is reduced in comparison
to those of the majority group (Branco et al., 2016). In this study, only 6% of
the sample belong to the OUD group, so predicting the majority class, no OUD,

15

Table 1.4. Odds ratios with 95% confidence intervals (CIs)
Firth
FLIC
Age
0.011
0.011
(0.000, 0.172)
(0.000, 0.172)
Gender
0.019
0.019
(0.000, 0.489)
(0.000, 0.489)
Time on Mechanical
0.011
0.011
Ventilation
(0.000, 0.226)
(0.000, 0.226)
Length of Stay in ICU 404.171
404.171
(9.156,
(9.156,
2589446.577)
2589446.577)
Hyperlipidemia
0.000
0.000
(0.000, 0.030)
(0.000, 0.030)
Anxiety disorder
0.019
0.019
(0.000, 0.436)
(0.000, 0.436)
Alcohol use disorder
0.001
0.001
(0.000, 0.131)
(0.000, 0.131)
ND or personal
1386.617
1386.617
history of ND
(19.209,
(19.209,
36291964.460)
36291964.460)
Medicare or Medicaid 0.020
0.020
(0.000, 0.967)
(0.000, 0.967)

in Firth models
FLAC
0.011
(0.000, 0.109)
0.018
(0.000, 0.300)
0.009
(0.000, 0.133)
440.647
(17.173,
65033.350)
0.000
(0.000, 0.012)
0.018
(0.000, 0.282)
0.000
(0.000, 0.048)
1462.239
(38.178,
472565.953)
0.017
(0.000, 0.470)

for all patients can also achieve an accuracy of 94%. But, all the patients in
the minority group will be misclassified and the potential risk of OUD cannot be
detected. Hence, besides accuracy and AIC, we also reported the recall (sensitivity
or true positive rate), specificity (true negative rate), precision, and F1-score,
which combines recall and precision (Rijsbergen, 1979). As shown in Table 1.5,
Firth logistic regression, FLIC and FLAC have higher scores for recall, specificity,
precision and F1-score than Lasso logistic regression. Especially, Firth logistic
regression has the highest F1-score of 0.961, and predicted all the positive cases
correctly. The performance of FLIC and FLAC were similar.
The receiver operating characteristics (ROC) curve and the corresponding area
under the ROC curve (AUC) are also very popular in imbalance data prediction
(Metz, 1978). The ROC curve visualizes of the relative trade-off between true
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positive rate and false positive rate. The ROC curves with AUC for 4 models are
shown in Figure 1.1. Three Firth models have similar curves, while Firth logistic
regression has the highest AUC of 0.933. Overall, the Firth models outperformed
Lasso logistic regression.
Precision-recall curves (PR curves) are also recommended for highly imbalanced data to evaluate model performance (Davis and Goadrich, 2006). Figure 1.2
shows the PR curves for 4 models. The curves of Firth logistic regression and FLIC
overlap. At thresholds with low recall, the precision is correspondingly higher for
3 Firth models, which indicates 3 Firth models slightly outperformed the lasso
model. But as recall scores increased, the precision scores became close in all 4
models, which may be caused by the extreme imbalanced classes.
Table 1.5. Model Performance
Recall Specificity Accuracy Precision
Lasso 0.000 0.000
0.971
0.000
Firth 0.925 1.000
0.928
1.000
FLIC 0.925 0.500
0.913
0.500
FLAC 0.925 0.500
0.913
0.500

Metrics
F1-score
0.000
0.961
0.649
0.649

AUC
0.896
0.933
0.933
0.925

Figure 1.1. ROC curves for 4 models with AUC

AIC
-19.903
68.311
67.785
75.712
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Figure 1.2. Precision-recall curves for 4 models
1.4

Discussion
The aim of the current study was to identify significant risk factors associ-

ated with OUD and establish a prediction model for OUD diagnosis among ICU
patients using Electronic Health Records. This study focused on the challenges
introduced by imbalanced data with high dimensional features and utilized two
types of penalized logistic regression, including Lasso and Firth logistic regression,
and two modifications of Firth model as alternatives to the classical logistic regression in order to avoid overfitting and biased estimate and improve the predictive
power for minority group.
This study found 19 significant risk factors associated with OUD from 4 models. Predictors shared across all 4 models include age at admission, hyperlipidemia,
alcohol use disorder (AUD), and nicotine dependence (ND) or personal history of
ND. Some classification studies have reported that a younger age is a significant
predictor for opioid misuse (Webster, 2017; Turk et al., 2008; Ives et al., 2006;
Edlund et al., 2007). Hyperlipidemia, and a history of non-opioid substance abuse
are also supported as consistent predictors for OUD in two recent machine learning models (Segal et al., 2020; Lo-Ciganic et al., 2020). The strong association
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between heavy smoking/nicotine dependency and opioid misuse was also found in
a large representative sample from the National Survey on Drug Use and Health
(Zale et al., 2014). Our study reinforced the important role of age, hyperlipidemia,
AUD, and ND or a personal history of ND in the prediction of OUD.
The comparison of coefficient estimates suggests FLIC can most accurate estimates with least bias. A previous simulation study also reported FLAC may
introduce some bias in the effect estimation in order to achieve a better prediction
performance (Puhr et al., 2017). However, in this study, Firth logistic regression
outperformed FLIC and FLAC with the highest F1-score, which may be related
to the small prevalence of OUD patients in a limited sample size. Puhr et al.
suggested increasing sample size and expected event rate can reduce the difference
between Firth logistic regression and FLIC/FLAC (Puhr et al., 2017). Furthermore, comparing 3 Firth models with Lasso logistic regression, we found Firth
models, especially the ordinary Firth logistic regression, had more power in detecting minority but meaningful cases than Lasso logistic regression.
The current study has some limitations. First, the sample was extracted from
one location at one single time point, which might not be able to represent the
population and did not consider the longitudinal effect of some factors, such as
history of opioid medication use. Second, our sample has a limited size and the
number of OUD patients was very small. Even though we applied penalized methods to handle these issues, the performance of classification models heavily depend
on the amount of data used for training. So the PR curves for 4 models in our
study showed poor performance. Finally, we did not utilize any resampling method
to get a more balanced data for OUD prediction because we believe the original
data can better characterize the pattern of OUD patients in the realistic medical
settings. However, this choice also sacrificed partial accuracy of the prediction.
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Given the limitations in our sample, future study should focus on increasing the sample size and the representativeness of the sample by integrating more
patients’ records from multiple locations, as well as incorporating more potential
risk factors, such as longitudinal records of opioid medication use, and the severity
of certain physical/mental condition. To improve the prediction performance in
the future, we can utilize some resampling methods to oversample the cases in
the minority class, such as synthetic minority over-sampling technique (SMOTE)
(Chawla et al., 2002).
Strengths of the current study involves both practical and methodological aspects. We extracted 30 physical/mental conditions based on ICD-10 code and
investigated their associations with OUD in a real-world medical setting. We identified several strong predictors for clinicians to consider when assessing the risk
of OUD among ICU patients. In addition, we utilized several penalized logistic regression to select significant predictors from a large amount of features and
adopted Firth logistic regression and its modifications to adjust the estimate and
prediction bias in the case of imbalanced classification. Our results illustrate with
Firth penalization, logistic regression can classify minority cases more correctly.
1.5

Conclusion
As opioid crisis continues to grow across the U.S., efforts to provide timely

intervention and better healthcare for patients at high risk of opioid misuse have
become more urgent. This study sought to shed insight on predictors of OUD in
a real-world sample of ICU patients, and observed that a variety of demographic,
mental, behavioral and physical predictors contributed to the risk of opioid misuse. Our findings obtained in the comparison of model estimation and prediction
suggest that Firth penalized logistic regression and its modifications, FLIC and
FLAC, are favorable to predict rare cases in imbalanced data.

20
List of References
(2017). Dsm-5 diagnose and new icd-10-cm codes.
Abdullah, M. N., Wah, Y. B., Zakaria, Y., Majeed, A. B. A., and Huat, O. S.
(2019). Discovering potential blood-based cytokine biomarkers for alzheimer’s
disease using firth logistic regression. Epidemiology, Biostatistics and Public
Health, 16(4).
Bilal, M., Chatila, A., Siddiqui, M. T., Al-Hanayneh, M., Shah, A. R., Desai, M.,
Wadhwa, V., Parupudi, S., Casey, B. W., Krishnan, K., et al. (2019). Rising
prevalence of opioid use disorder and predictors for opioid use disorder among
hospitalized patients with chronic pancreatitis. Pancreas, 48(10):1386–1392.
Bogdanowicz, K. M., Stewart, R., Broadbent, M., Hatch, S. L., Hotopf, M., Strang,
J., and Hayes, R. D. (2015). Double trouble: Psychiatric comorbidity and
opioid addiction—all-cause and cause-specific mortality. Drug and alcohol
dependence, 148:85–92.
Box, M. (1971). Bias in nonlinear estimation, jr statist. Soc. B, 32:171–201.
Branco, P., Torgo, L., and Ribeiro, R. P. (2016). A survey of predictive modeling
on imbalanced domains. ACM Computing Surveys (CSUR), 49(2):1–50.
Brick, J. (2012). Handbook of the Medical Consequences of Alcohol and Drug Abuse
(second ed.). The Haworth Press, Taylor and Francis Group, New York.
CDC and NCHS (2020). Wide-ranging online data for epidemiologic research
(wonder).
Chawla, N. V., Bowyer, K. W., Hall, L. O., and Kegelmeyer, W. P. (2002). Smote:
synthetic minority over-sampling technique. Journal of artificial intelligence
research, 16:321–357.
Ciesielski, T., Iyengar, R., Bothra, A., Tomala, D., Cislo, G., and Gage, B. F.
(2016). A tool to assess risk of de novo opioid abuse or dependence. The
American journal of medicine, 129(7):699–705.
Davis, J. and Goadrich, M. (2006). The relationship between precision-recall and
roc curves. In Proceedings of the 23rd international conference on Machine
learning, pages 233–240.
Dreiseitl, S. and Ohno-Machado, L. (2002). Logistic regression and artificial neural
network classification models: a methodology review. Journal of biomedical
informatics, 35(5-6):352–359.
Edlund, M. J., Steffick, D., Hudson, T., Harris, K. M., and Sullivan, M. (2007).
Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain, 129(3):355–362.

21
Firth, D. (1993). Bias reduction of maximum likelihood estimates. Biometrika,
80(1):27–38.
Friedman, J., Hastie, T., and Tibshirani, R. (2010). Regularization paths for
generalized linear models via coordinate descent.
Han, D.-H., Lee, S., and Seo, D.-C. (2020). Using machine learning to predict
opioid misuse among us adolescents. Preventive medicine, 130:105886.
Hastie, T., Tibshirani, R., Friedman, J. H., and Friedman, J. H. (2009). The elements of statistical learning: data mining, inference, and prediction, volume 2.
Springer.
Heinze, G., Ploner, M., and Jiricka, L. (2022). logistf: Firth’s Bias-Reduced Logistic
Regression. R package version 1.24.1.
Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac,
J. S., Potisek, N. M., Shilliday, B. B., DeWalt, D. A., and Pignone, M. P.
(2006). Predictors of opioid misuse in patients with chronic pain: a prospective
cohort study. BMC health services research, 6(1):46.
Katz, C., El-Gabalawy, R., Keyes, K. M., Martins, S. S., and Sareen, J. (2013).
Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample. Drug
and alcohol dependence, 132(1-2):107–113.
Langabeer, J. R., Stotts, A. L., Bobrow, B. J., Wang, H. E., Chambers, K. A.,
Yatsco, A. J., Cardenas-Turanzas, M., and Champagne-Langabeer, T. (2021).
Prevalence and charges of opioid-related visits to us emergency departments.
Drug and alcohol dependence, 221:108568.
Lapham, G., Boudreau, D. M., Johnson, E. A., Bobb, J. F., Matthews, A. G.,
McCormack, J., Liu, D., Samet, J. H., Saxon, A. J., Campbell, C. I., et al.
(2020). Prevalence and treatment of opioid use disorders among primary care
patients in six health systems. Drug and alcohol dependence, 207:107732.
Lo-Ciganic, W.-H., Huang, J. L., Zhang, H. H., Weiss, J. C., Kwoh, C. K., Donohue, J. M., Gordon, A. J., Cochran, G., Malone, D. C., Kuza, C. C., et al.
(2020). Using machine learning to predict risk of incident opioid use disorder
among fee-for-service medicare beneficiaries: A prognostic study. PloS one,
15(7):e0235981.
Mattson, C., Tanz, L., Quinn, K., Kariisa, M., Patel, P., and Davis, N.
(2021). Trends and geographic patterns in drug and synthetic opioid overdose deaths— United States, 2013–2019. MMWR Morb Mortal Wkly Rep
2021, 70:202–207.

22
Metz, C. E. (1978). Basic principles of roc analysis. In Seminars in nuclear
medicine, volume 8, pages 283–298. Elsevier.
Michna, E., Ross, E. L., Hynes, W. L., Nedeljkovic, S. S., Soumekh, S., Janfaza, D.,
Palombi, D., and Jamison, R. N. (2004). Predicting aberrant drug behavior
in patients treated for chronic pain: importance of abuse history. Journal of
pain and symptom management, 28(3):250–258.
Montiel Ishino, F. A., McNab, P. R., Gilreath, T., Salmeron, B., and Williams,
F. (2020). A comprehensive multivariate model of biopsychosocial factors
associated with opioid misuse and use disorder in a 2017–2018 united states
national survey. BMC public health, 20(1):1–16.
NIDA (2021). Overdose death rates. national institute on drug abuse.
Puhr, R., Heinze, G., Nold, M., Lusa, L., and Geroldinger, A. (2017). Firth’s
logistic regression with rare events: accurate effect estimates and predictions?
Statistics in medicine, 36(14):2302–2317.
R Core Team (2018). R: A Language and Environment for Statistical Computing.
R Foundation for Statistical Computing, Vienna, Austria.
Rahman, M. S. and Sultana, M. (2017). Performance of firth-and logf-type penalized methods in risk prediction for small or sparse binary data. BMC medical
research methodology, 17(1):1–15.
Rajkomar, A., Oren, E., Chen, K., Dai, A. M., Hajaj, N., Hardt, M., Liu, P. J.,
Liu, X., Marcus, J., Sun, M., et al. (2018). Scalable and accurate deep learning
with electronic health records. NPJ Digital Medicine, 1(1):1–10.
Rijsbergen, C. (1979). Information retrieval 2nd ed buttersworth. London [Google
Scholar].
Rojas, J. C., Carey, K. A., Edelson, D. P., Venable, L. R., Howell, M. D., and
Churpek, M. M. (2018). Predicting intensive care unit readmission with machine learning using electronic health record data. Annals of the American
Thoracic Society, 15(7):846–853.
SAMHSA (2020). Key substance use and mental health indicators in the United
Statess: Results from the 2019 national survey on drug use and health (hhs
publication no. pep20-07-01-001, nsduh series h-55). Center for Behavioral
Health Statistics and Quality, Substance Abuse and Mental Health Services
Administration.
Segal, Z., Radinsky, K., Elad, G., Marom, G., Beladev, M., Lewis, M., Ehrenberg,
B., Gillis, P., Korn, L., and Koren, G. (2020). Development of a machine
learning algorithm for early detection of opioid use disorder. Pharmacology
Research & Perspectives, 8(6):e00669.

23
Su, C., Aseltine, R., Doshi, R., Chen, K., Rogers, S. C., and Wang, F. (2020).
Machine learning for suicide risk prediction in children and adolescents with
electronic health records. Translational psychiatry, 10(1):1–10.
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of
the Royal Statistical Society: Series B (Methodological), 58(1):267–288.
Turk, D. C., Swanson, K. S., and Gatchel, R. J. (2008). Predicting opioid misuse
by chronic pain patients: a systematic review and literature synthesis. The
Clinical journal of pain, 24(6):497–508.
Webster, L. R. (2017). Risk factors for opioid-use disorder and overdose. Anesthesia
& Analgesia, 125(5):1741–1748.
Weiss, A. J., Elixhauser, A., Barrett, M. L., Steiner, C. A., Bailey, M. K., and
O’Malley, L. (2017). Opioid-related inpatient stays and emergency department
visits by state, 2009–2014: statistical brief# 219.
Zale, E. L., Dorfman, M. L., Hooten, W. M., Warner, D. O., Zvolensky, M. J., and
Ditre, J. W. (2014). Tobacco smoking, nicotine dependence, and patterns of
prescription opioid misuse: results from a nationally representative sample.
Nicotine & Tobacco Research, 17(9):1096–1103.

24

MANUSCRIPT 2
Shared Parameter Model of Longitudinal and Time-to-Event Data
with Missing Time-varying Covariates: An Application to Opioid Use
Disorder
2.1

Introduction
Electronic Health Record (EHR) data include a variety of variables that may

be critical for the development of opioid use disorder (OUD), such as personal
demographic information, comorbidities and disease history, medical procedures,
and medication prescriptions. If the patient repeatedly attended the same facility
or several facilities using the same EHR system, his/her visit records may be considered as longitudinal data. In the meanwhile, time to event data, such as the
time to the onset of a particular illness, can sometimes be studied together with
longitudinal and demographic information. Consequently, we may use EHR data
to investigate the associations between the longitudinal history of a variable and
its influence on the risk of an event. To achieve the goal of modeling both longitudinal and time-to-event data simultaneously, a class of joint model has been developed (De Gruttola and Tu, 1994; Tsiatis et al., 1995; Faucett and Thomas, 1996;
Wulfsohn and Tsiatis, 1997). Joint models for longitudinal and time-to-event data
are a powerful method that cannot only bring these two data types together in
a single model, but also take into consideration the dependence and relationship
between longitudinal and time-to-event data. Previous studies show joint models have the potential to lessen the burden of bias and improve the efficiency of
the estimations (Ibrahim et al., 2010; Zhang et al., 2014). Therefore, they have
gained increasing attention in the statistics field and been applied in a wide range
of studies in epidemiological and biomedical fields.
However, EHR data, unlike data from clinical trials used in previous joint
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model studies, have some commonly presented practical issues, such as missing
observations (Ward et al., 2015). This may pose challenges to accurate estimation
for the longitudinal data (Ghassemi et al., 2020; Rajkomar et al., 2018). There
are two categories of missing data in longitudinal studies, intermittent missing
and dropout. Intermittent missing refers to an unobserved value followed by an
observed value, while a missing value because of dropout has no follow-up observations (Gad and Darwish, 2013). Both are observed in EHR data. To handle
missing values in longitudinal data, the underlying mechanism of missingness needs
to be understood first. Missing mechanisms include missing completely at random
(MCAR), missing at random (MAR), and missing not at random (MNAR). A
missing variable is considered MCAR when the probability of missingness is independent of both observed and unobserved data, and MAR if the missingness only
depends on fully observed variables. When observations are MCAR or MAR, there
are three approaches we can use complete case analysis or multiple imputation
to handle missing values and achieve unbiased estimates (Little and Rubin, 2019;
Groenwold et al., 2012). Complete-case analysis only uses data from those subjects without any missing observations, and multiple imputation replaces the
missing values with a plausible values from multiple completed datasets. These
methods have been used widely in clinical trials or observational studies. But
these methods are valid under the assumption of MCAR or MAR. Especially,
when the degree of missing becomes large, removing incomplete cases will not
only produce biased estimates but also yield a large loss of information. When
the missing mechanism is neither MCAR nor MAR, the data are considered as
MNAR, where the missing probability of a variable depends upon its unobserved
value. Under MNAR, unbiased estimation needs to account for the probability
of missing, the distribution of the values of the missing variable and the rela-
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tionship between the incomplete variable and response variable. To model all
three elements simultaneously, selection models (Heckman, 1976), pattern mixture
models (Glynn et al., 1986) and shared parameter models (Wu and Carroll, 1988;
Gad and Darwish, 2013; Vonesh et al., 2006) were introduced. In a shared parameter model, a random effect is shared between longitudinal model and the missing
mechanism model. Many studies have used the shared parameter model for missing
values in longitudinal data and extended it to a wide range of response types, including continuous normally distributed response (Wu and Carroll, 1988), binary
response (Follmann and Wu, 1995) and count data (Albert and Follmann, 2000).
With the increasing research in joint model, there is also extensive literature
on missing data in joint models. Wu et al. incorporated a missing data mechanism into the joint model likelihood to explore informative dropouts in an AIDS
clinical trial, and used an expectation–maximization (EM) method inside the likelihood framework for the estimation of the model parameters (Wu et al., 2008).
Thiébaut et al. constructed a joint model for the bivariate linear mixed model
and survival model to account the effect of two longitudinal biomarkers, one of
which was subject to left censoring, and estimated the parameters using a direct
maximum likelihood approach (Thiébaut et al., 2005). Recently, Chen at al. introduced a Bayesian approach for a longitudinal study with censored and missing
time-varying covariate data within the joint-modeling framework to investigate the
longitudinal AIDS progression and failure from AIDS (Chen et al., 2014). In this
study, we aim to model the longitudinal and time to event data jointly within
a shared parameter framework. The shared parameter joint model is one of the
most common joint modelling approach in the literature. A shared parameter joint
model connects two related submodels, longitudinal and time-to-event submodels,
through a shared individual-level random effects. Due to this feature and the
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conditional independence assumptions, shared parameter models can handle both
intermittent missing and dropout easily without considering the missing longitudinal observations (Rizopoulos, 2012).
The motivation for this study lies in our interest in investigating available risk
factors that may be associated with the onset of opioid use disorder (OUD) among
emergency department (ED) patients. Data used in this study were collected from
2001 to 2012. During this period, according to a report of opioid prescription
pattern in 2009, the number of prescriptions for opioids from emergency department (EDs) was the third highest of all opioid prescription sources among the
patients younger than 29 years old, around 12% of the total prescriptions, and
the fourth highest in the 30-39-year-old age group (Volkow et al., 2011). Despite
the fact that these findings do not examine the total doses of opioid, it can also
be emphasized that the ED patients are at a high risk for opioid dependence and
abuse (Hansen, 2005). Factors related to OUD, such as medical history of opioid prescribed in ED, are of particular interest. Previous observational studies
suggest that opioid-naive patients prescribed first opioids in ED were at elevated
risk for long-term recurrent opioid use (Hoppe et al., 2015; Barnett et al., 2017;
Butler et al., 2016). In addition, Butler et al. found the time from initial exposure to onset of nonmedical use to get high ranged from 2 to 36 months, and
after a median of 12 months, the patient may start using regularly to get high
(Butler et al., 2016). Although the effect of opioid prescription from EDs on the
risk of OUD onset remains unclear, these previous studies showed evidence suggesting a further investigation. Hence, our objective of this study is to evaluate
how opioid prescription from EDs over time affect the onset of opioid use disorder.
However, a challenge of using EHR data for this analysis is there is a significant
portion of missing data, because it is unrealistic for everyone to come to the ED
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regularly like in clinical trials, and the length of time from the first visit to the
last visit varies from person to person in the system. Specifically, given the high
risk of overdose associated with opioid, we suspect that the data in longitudinal
opioid prescription is not MCAR. For pain management in ED, there are multiple
analgesic drugs that can be as effective as opioids. Before providers prescribed
opioid to a patients, they need to check patient’s medical history and conduct
an assessment of the pain, physical and psychological function. So, the missingness may be depend on other variables, such as history of substance use disorder
and chronic/acute pain conditions. Thus, we suspect the missing mechanism for
longitudinal opioid prescription doses in our data is MAR.
As previously noted, shared parameter models may handle complex missing
data and offer unbiased estimates. Hence, the main objective of this work is to
employ shared parameter models to jointly analyze longitudinal opioid prescription
dosages and time to OUD onset. The relationship between them is also examined
within the context of the joint model. In addition, we investigate the efficacy
of the shared parameter model with respect to missing longitudinal responses by
comparing estimates obtained under scenarios with different proportion of missing
data.
2.2 Methodology
2.2.1 Motivating Data
The current study is conducted using an open-access dataset, Medical Information Mart for Intensive Care III (Mimic-III)(Johnson et al., 2016) provided by the
Massachusetts Institute of Technology. This dataset is composed of de-identified,
comprehensive clinical data of patients admitted to the critical care units of the
Beth Israel Deaconess Medical Center in Massachusetts between 2001 and 2012.
It includes 58,976 admissions from 48,520 distinct adult patients, with 1190 adult
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patients having OUD related diagnosis. The dataset has been used for different research purposes such as discharge or mortality prediction (McWilliams et al., 2019;
Pirracchio et al., 2015). It should be noted that all dates in this dataset have been
shifted randomly to protect patient confidentiality, which means dates are internally consistent for the same patient, but cannot represent the actual time.
In this study, we first identified patients with opioid prescription using National Drug Code (NDC) (CDC, 2021). In this data, we found two types of opioids,
fentanyl citrate and morphine sulfate. Then, we selected patients with at least 5
visits. The time of patients’ first opioid prescription is used as the baseline reference time. For each patient, we calculated the interval between each of his/her
subsequent visits and the reference time on a monthly basis. The event of interest
is the onset of first OUD diagnosis, which is coded based on OUD diagnosis ICD-9
codes, include 304.00–304.03 (Opioid type dependence), 304.70–304.73 (Combinations of opioids with any other), 305.50–305.53 (Nondependent opioid abuse), 965.0
(Poisoning; Opiates and Related Narcotics), 965.00 (Poisoning; Opium/alkaloids,
unspecified), 965.01 (Poisoning; Heroin), 965.02 (Poisoning; Methadone), 965.09
(Poisoning; Other opiates and related narcotics), E85.00 (Accidental Poisoning;
Heroin), E85.01 (Accidental Poisoning; Methadone), 97.01 (Poisoning; Opiate antagonists) and E85.02 (Accidental Poisoning; Other Opiates and Related Narcotics) (Heslin et al., 2015). We considered the time from a patient’s first opioid
prescription to first diagnosis for OUD. Time-independent covariates include age
of first opioid prescription, chronic pain condition indicator, admission type of first
opioid prescription, and insurance type.
The time-varying longitudinal variable is the total dosage of opioid prescription. Since we have two types of opioid, we transformed the dosage of fentanyl to
equivalent dosage of morphine. A dose of 100 mcg fentanyl is approximately equiv-
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alent in analgesic activity to 10 mg of morphine (FDA, 2013). If multiple doses of
the same opioid were prescribed in the same month, we merged those prescriptions
and calculated a total dosage of opioid prescription. Any values larger than 1,000
mg of morphine were excluded from the analysis as extreme outliers. After preprocessing, there are 43.9% missing intermittently in the longitudinal variable. A
trajectory plot for opioid dosage for a random sample of 20 patients in the study
is given in Figure 2.1. We can observe obvious individual level differences so we
used a mixed model to account for individual level random effect in longitudinal
variable.

Figure 2.1. Trajectory of opioid prescription dosage from 20 random patients

2.2.2

Longitudinal Submodel

Longitudinal data consist of repeated measurements for each individual over
time. Each individual in the sample is expected to have his/her own individual level
pattern over time. This between-person variability is accounted for by the mixedeffects model, which estimates person-specific random effects around parameters
that are fixed across persons (Laird and Ware, 1982).
Let yi (t) denote a longitudinal variables observed at the time t(t = 1, . . . , Ti∗ )
for the ith (i = 1, . . . , N ) individual in a sample of N individuals, where Ti∗ is the
time-to-event for individual i. We specify a linear mixed model for the longitudinal
opioid prescription dosage as:
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yi (t) = Xi (t)β + Zi (t)bi + ϵi (t)

(2.1)

where Xi (t) and Zi (t) represent the design matrix containing the predictors for
the fixed effects regression coefficients β and for the random effects regression
coefficients bi , respectively. The random effects bi = (bi0 , bi1 )′ are for random
intercept and slope effects. The measurement error term ϵi (t) is the error term
for individual i at time t. All the error terms are assumed mutually independent,
independent of bi , and normally distributed with mean zero and variance σ 2 .
2.2.3

Time-to-event Submodel

Time-to-event analysis, also known as survival analysis, refers to statistical
approaches to analyze time-to-event data. An event time is the length of time
that has passed until an event of interest, such as a death or a disease diagnosis,
happened. In time-to-event data, when the event of interest might not occur for
every individual within the study period, or an individual drops out before the end
of the study, this type of missing data is treated as right censored data. There
are several different models for time-to-event analysis (Kaplan and Meier, 1958).
Cox proportional hazard (PH) model is one of the most popular models, where
the multiplicative effect of covariates on the hazard for an event is modeled in a
regression (Cox, 1972). The baseline hazard function in COX PH model has no
exact pre-specificed form and is estimated non-parametrically. We specify a COX
PH model for the time to OUD onset as:

hi (t) = h0 (t)exp(γ T wi ),

(2.2)

where h0 (t) is the baseline hazard function at time t and wi is a vector of baseline
explanatory covariates with corresponding coefficients γ.
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2.2.4

Shared Parameter Framework for the Joint Model

The longitudinal and time-to-event submodels can be connected through
shared random-effects (Wulfsohn and Tsiatis, 1997). Under this framework, only
the random effects from the longitudinal submodel in Equation 2.1 are included
in the relative risk model. The random effects (intercept and slope) represent the
individual departures from the sample mean. Therefore, the association parameters used to interconnect the random effect and relative risk models reflect the
change in log hazard for a one-unit change in these deviations. Based on this
shared parameter model, we can see how an individual’s baseline observation of
the longitudinal data (random intercept) and longitudinal trend (random slope)
impact his/her probability of encountering the event of interest.
The joint model for longitudinal and time-to-event model assumes a full joint
distribution for the longitudinal responses, survival process and random effects as
(Armero et al., 2018):
Z
p(yi , Ti , δi ) =

p(yi |bi ){h(Ti |bi )δi S(Ti |bi )}p(bi )dbi ,

(2.3)

where yi is the longitudinal variable, Ti is the observed event time for patient i,
and δi is the event indicator. For the survival process, the survival function for
patient i is S(Ti |bi ) and the relative risk model is h(Ti |bi ). The random effects bi
explain all interdependencies.
Here, we define a set of conditional independence assumptions for the shared
parameter joint model, that is: (i)yi (t) ⊥ Ti∗ |bi ; (ii)yi (t) ⊥ yi (t′ )|bi . Assumption (i)
implies that the longitudinal outcome is independent of the time-to-event outcome,
while Assumption (ii) assumes that the repeated measurements in the longitudinal
outcome are independent of each other. Then, with the two submodels we defined
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in previous section, we can specify the joint model as:
yi (t) = Xi (t)β + Zi (t)bi + ϵi (t),
hi (t|h0 , γ, α, bi ) = h0 (t)exp(γ T wi + αZi (t)bi ),
where α is the association parameter, and Zi (t)bi is the random effect. And the
survival function for individual i is defined as:
Z t
Si (t|ho , γ, α, bi ) = exp{−
hi (s|h0 , γ, α, bi )ds},
0

which can be approximated using Gaussian quadrature method (Rizopoulos, 2012).
We built the model in R (R Core Team, 2018) using rjags (Lunn et al., 2009)
and runjags (Denwood, 2016). The model defined in JAGS is shown in Appendix
A.1. In terms of the Gaussian quadrature method used for integration estimation,
we used the package statmod (Giner and Smyth, 2016).
2.2.5

Missing Data

Shared parameter framework allows the joint model for longitudinal and timeto-event data to handle missing values easily given the conditional independence
assumptions. Let yio denote the observed longitudinal responses, and yim denote
the unobserved missing values. Then, the log likelihood under the complete data
model {yio , yim } for longitudinal data is defined as:

l(θ) =

=

N
X
i=1
N
X

Z
log

p(Ti , δi , yio , yim ; θ)dyim
(2.4)

Z
log

Z
p(Yi , δi |bi ; θ){

p(yio , yim |bi ; θ)dyim }p(bi ; θ)dbi

i=1

Under Assumption (i), the missing longitudinal responses yim are only involved in the density function of the longitudinal submodel. In addition, under
Assumption (ii), the longitudinal responses conditionally on the random effects are
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independent with each other, so the integral of yim in Equation 2.4 can be dropped.
Then, we have the log likelihood specified as :
Z
N
X
l(θ) =
log p(Yi , δi |bi ; θ)p(yio |bi ; θ)p(bi ; θ)dbi ,

(2.5)

i=1

which can be obtained without considering the integration with respect to the
missing at random responses.
A simulation study was conducted to evaluate the performance of the shared
parameter joint model regarding the percentage of missing values in Appendix B.
2.3

Results
As described before, we included 4 time-independent covariates, including age

of first opioid prescription, chronic pain condition indicator, admission type of
first opioid prescription, and insurance type in the time-to-event submodel. For
the longitudinal dosage of opioid prescription, we only included fixed and random
effects of time. Another strategy to handle missing values was also used, imputation using the last available observation, to create a complete dataset. Shared
parameter joint models were fit for the complete dataset and the original dataset
separately using 3 chains of 10,000 MCMC iterations, which included 1,000 burn-in
iterations. The estimates for the parameters are reported in Table 2.4 and 2.5.
From Table 2.4 and 2.5, the potential scale reduction factor (psrf) scores
are close to 1, indicating that each of the simulated observations is close to the
target distribution. By comparing the estimated in two models, we can find that
imputing missing opioid prescription with last available observation increases the
mean standard deviation (SD) of the posterior distribution and may be not be able
to reflect the real distribution of the data. In addition, in the model using imputed
data, none of the covariates are significant predictors for the event time. In the
shared parameter joint model with missing values, the SDs are smaller than those
in the imputed model. In addition, the association parameter, α, is 0.041 with
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Table 2.1. Parameter estimates for last observation imputed opioid prescription
Mean SD
Lower CI Median Upper CI psrf
γ0
20.8
15
-5
19.8
51.9
1.06
γ1
-17.2 11.5 -39.7
-15
0.384
1.02
γ2
-12.1 11.8 -36.9
-9.1
3.95
1.13
γ3
0.018 0.093 -0.158
0.014
0.209
1
γ4
-24
19.4 -62.2
-20.2
4.26
1
α
-0.004 0.006 -0.017
-0.004
0.006
1
β00
106
8.61 91
106
124
1.14
β10
0.522 0.397 -0.262
0.552
1.31
1.03
Notes: γ0 is the intercept, and γ1 , γ2 , γ3 , γ4 are the coefficients for baseline
covariates, insurance type, admission type, age of first opioid prescription
and pain condition indicator.α is the association parameter and (β00 , β10 )′ is the
fixed effect for time.
Table 2.2. Parameter estimates for opioid prescription
Mean SD
Lower CI
γ0 (intercept)
-4.47 2.77 -10.2
γ1 (insurance type)
-0.821 1
-2.49
γ2 (admission type)
0.717 1.48 -2.35
γ3 (age of first opioid)
-0.056 0.036 -0.132
γ4 (pain condition indicator) 0.068 1.38 -2.72
α (association parameter)
0.041 0.021 0.010
β00
57.6
3.67 50.7
β10
0.528 0.171 0.188
′
Notes:(β00 , β10 ) is the fixed effect for time.

with missing values
Median Upper CI
-4.48
0.872
-0.732
0.848
0.832
3.49
-0.052
0.008
0.211
2.71
0.037
0.082
57.6
64.9
0.528
0.862

psrf
1.01
1.08
1.01
1.08
1.03
1.22
1
1

95% credible interval (0.010, 0.082), indicating a significant positive association
between opioid prescription and the onset of OUD.
Then, we removed several covariates with large SDs and only included age of
first opioid prescription and pain condition indicator as the covariates in the timeto-event submodel. The shared parameter joint model was fit again with 3 chains
of 10,000 MCMC iterations, including 1,000 burn-in iterations. The estimates
obtained from this reduced model are shown in Table 2.6.
The potential scale reduction factor (psrf) scores are closer to 1 than those in
the full model, indicating a better convergence of the reduced joint model. In the
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reduced joint model, the association parameter, α, is still significant. Moreover,
the coefficient for age of first opioid prescription, γ1 , is -0.062 with 95% credible
interval (-0.114, -0.011), which suggests a significant negative association between
the age of first opioid and OUD onset.
Table 2.3. Parameter estimates for opioid prescription in reduced
Mean SD
Lower CI Median
γ0 (intercept)
-4.79 2.31 -9.32
-4.79
γ1 (age of first opioid)
-0.062 0.026 -0.114
-0.061
γ2 (pain condition indicator) -0.216 1.44 -3.11
-0.041
α (association parameter)
0.034 0.014 0.009
0.033
β00
57.4
3.61 50.3
57.3
β10
0.532 0.173 0.185
0.532
′
Notes: (β00 , β10 ) is the fixed effect for time.

joint model
Upper CI
-0.288
-0.011
2.35
0.063
64.5
0.863

psrf
1.02
1.01
1.01
1.02
1
1

Table 2.4. Comparison of Deviance Information Criteria (DIC)
Model
DIC
Joint model with imputed values 688.7
Full joint model
107.9
Reduced joint model
81.09
The comparison of Deviance Information Criteria (DIC) are shown in Table
2.7, and shows that the reduced model with raw data has the lowest DIC and is
more favorable than the other two models. Figure 2.2 - 2.4 provides trace plots for
parameters of interest from three models. Comparing the trace plots, we observe
that the chains in reduced joint model mixed better than those in the other two
models, suggesting a better convergence.
2.4

Discussion
In this study, we used a joint model for longitudinal and time-to-event

data within the shared parameter framework. As suggested in a previous study
(Rizopoulos, 2012), the shared parameter framework allows us to make unbiased
estimations without considering the unobserved longitudinal responses. The simu-
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Figure 2.2. Trace plots of selected parameters from model with imputed data
lation results show under assumption of MNAR, even when the missing proportion
is as large as 40%, the estimates for covariates in the time-to-event submodel are
still close to the true values. However, the estimates for the fixed effect in the
longitudinal submodel and the association parameter were less satisfactory. In the
real data application, the joint model with less covariates performed better than
the full joint model and the joint model with imputed longitudinal responses.
The posterior distribution of association parameter, α, suggest a weak positive
association between longitudinal opioid prescription dosage and the OUD onset.
A prior observational study that assessed the prevalence of recurrent opioid usage
after an ED opioid prescription revealed that around 30% of all opioid-naive patients prescribed first opioids in EDs went on to engage in recurrent use and were
at increased risk for further opioid use one year later (Hoppe et al., 2015). Barnett
et al. found among Medicare beneficiaries prescribed a new opioid in the ED, one
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Figure 2.3. Trace plots of selected parameters from full joint model
out of every 48 patients will become a long-term user (Barnett et al., 2017). Another cross-sectional study observed that among ED pateints who reported heroin
or prescription opioid abuse and were initially exposed to opioid by a medical
prescription, around 30% of them received their first opioids from an ED prescription (Butler et al., 2016). Although these studies suggested opioid prescription in
EDs may increase the risk of opioid dependence, the relationship between medical history of opioid prescription and the onset of OUD is still unclear. Our
findings show higher values or increasing trends of opioid prescription dosage increase the risk of OUD. Another significant predictor for the time to OUD onset
is the age of initial opioid prescription. Younger age has always been supported
to be a significant predictor for opioid misuse (Webster, 2017; Turk et al., 2008;
Ives et al., 2006; Edlund et al., 2007). Our study focuses on the opioid prescribed
from EDs and noted a similar finding. The younger the patient is when he/she get
his/her first opioid prescription from EDs, the greater the risk of OUD becomes.
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Figure 2.4. Trace plots of selected parameters from reduced joint model
This study has limitations. First, in the shared parameter joint model, we
only considered a shared random effect as association. There are some different
association structures for joint model for longitudinal and time-to-event model.
For example, the current value association assumes that for individual y, the true
value of the longitudinal measure at time t is directly related to the risk hi (t) of
experiencing the event at that same time t. Then, the joint model can be specified
as:
hi (t) = h0 (t)exp(γ T wi + αµi (t)),
where µi (t) = Xi (t)β + Zi (t)bi is the true value of the longitudinal response.
This structure requires the longitudinal submodel to be pre-specified accurately
to model the repeatedly observed measurements. Other kinds of association structures also include shared random and fixed effects, current slope, cumulative effects,
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etc. Hence, based on the nature of the data, we may consider a different association structure. Second, in this study, we used the Gaussian quadrature method
(Rizopoulos, 2012) to approximate the integration in survival function. However,
there are some other approaches for the full joint likelihood function, such as
adaptive Gauss-Hermite quadrature (Crowther et al., 2012) and Monte-Carlo simulation (Thiébaut et al., 2005). In addition, we can also obtain estimations from
the joint model under a Bayesian approach, which we would like to conduct in the
future.
2.5

Conclusion
In conclusion, this study conducted a joint analysis of longitudinal and time-

to-event data using a shared parameter framework with special consideration of
missingness in EHR. A significant association between longitudinal dosage of opioid prescription and the onset of OUD diagnosis is detected in the joint model.
Providers should check the history of opioid use and consider a variety of risk
factors before prescribing an opioid medication in EDs.
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MANUSCRIPT 3
Predicting Risk of Opioid Dependence and Abuse using Deep Learning
with Static and Temporal Features
3.1

Introduction
According to the most recent data release, 91,799 Americans died from drug

overdoses in 2020, 74.8% of which involved opioids (Hedegaard et al., ). And
among all opioid overdoses deaths in 2020, 16,000 deaths, more than 23%, is related
to prescription opioids, with over a 16% increase in prescription opioid-involved
death rates from 2019 to 2020. (CDC, 2021). On average, 44 people died everyday
from overdoses involving prescription opioids. This number increased almost by
five times from 1999 to 2020 (CDC, 2021). Despite this alarming trend, the quantity of opioids prescribed per person in terms of morphine milligram equivalents
(MME) is still around three times greater than it was in 1999 (Guy Jr et al., 2017).
In 2017, for every 100 people in the United States, around 58 people were administered prescription opioids, with an average of 3.4 prescriptions per patient
(Hoots et al., 2018).
CDC has been encouraging evidence-based research to identify risk and
protective factors and develop effective strategies to prevent opioid-related
harms.

A key challenge in prevention is the timely identification of peo-

ple at high risk for opioid dependence or abuse.

Common tools used to as-

sess specific opioid-related risk in clinical practice, such as the Opioid Risk
Tool (ORT) (Webster and Webster, 2005), the Screener and Opioid Assessment
for Patients with Pain (SOAPP) (Akbik et al., 2006), and its revised version
(Butler et al., 2009), focus on substance use disorder history, family history of substance use disorder, and significant psychological problems. However, the opioid
dependence or abuse is not only associated with social and behavioral factors but
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also with physiological and biomedical factors (Ellis et al., 2019; Dong et al., 2019;
Katz et al., 2013; Lo-Ciganic et al., 2019). A previous study has shown that the
accuracy of the ORT and SOAPP-Rivised in predicting subsequent problematic
opioid misuse is questionable (Jones and Moore, 2013). To ensure an informed
opioid prescribing practice, further effort is needed to develop a comprehensive
and reliable opioid-related risk assessment and prediction tool.
With the development of machine learning technology, several prior studies utilized machine learning models to predict opioid-related risks and produced
a promising accuracy. Ellis et al. implemented several Random Forest classifiers to predict opioid dependence using lab results and vital signs during 10
or 20 days prior to first substance-related diagnosis (Ellis et al., 2019). With
missing data imputation using median or mean, their best classifier can predict
whether a patient has substance dependence around 92% of the times. Karhade
et al. developed a elastic-net penalized logistic regression to predict continuous
opioid prescriptions after total hip arthroplasty (THA) (Karhade et al., 2019b)
and achieved a good performance with the area under the receiver operating
curve (AUC) of 0.77.

However, these studies ignored the temporal patterns

within the data (Karhade et al., 2019b; Karhade et al., 2019a; Ellis et al., 2019;
Dong et al., 2019). They either measured predictors at a single time point, or
treated multiple encounters of one patient as different cases.
Recent studies are attempting to overcome this limitation. Some studies extract some values from fixed time windows, such as the duration, the average value,
or the cumulative counts. Lo-Ciganic et al., for example, used cumulative and duration of opioid usage time in 3 months to reflect patient’s opioid use pattern in
ML models to predict the risk of OUD in the next 3-month window after initial
prescription (Lo-Ciganic et al., 2019; Lo-Ciganic et al., 2020). Even though these
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methods allow traditional ML algorithms to be used directly, they have downsides
that i) some of the useful temporal information is lost; ii) estimates highly reply on human-assigned duration, requiring extra time and professional help. Deep
learning, such as Recurrent Neural Networks (RNN), has been proven very successful in capturing complex temporal relationships among time-dependent features.
However, few studies used RNN models with raw temporal data to predict opioid
dependence or abuse.
Electronic health records (EHRs) are a valuable resource for developing a deep
learning model for predicting opioid-related risk. There are a variety of data types,
including features, such as demographic information and disease history, and temporal data during patients’ visits, such as lab test results and outputs over time.
However, clinical measurements in EHRs, unlike measurement in experimental
studies, are not collected simultaneously at equally spaced time intervals and may
not have the same length (Bampa, 2019). In addition, missing observations are
common in EHRs due to practical issues. RNN models, such as Long Short-Term
Memory (LSTM) and Gated Recurrent Unit (GRU), are incapable of efficiently
addressing these irregularly gathered or missing measurements. Additional works
are always needed to filter complete cases only or impute missing values using
the last available observation, median or MICE. These missing imputation methods may lose valuable information about the time each observation was recorded.
Moreover, most missing imputation methods need to be conducted based on the
assumption of missing randomness, which is hard to check in EHR data. To deal
with this issue, Che et al. proposed GRU-D which modifies the standard GRU
by adding a decay rate γt to models decay mechanism of inputs and hidden output states (Che et al., 2018). GRU-D is built based on two assumptions of missing
value mechanism in EHR data: i) the missing values of certain features will become
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some default values if the time between last observation and missing observation is
long enough and ii) as time passes, the influence of previous observations will decrease. This decay rate can be trained with the model and used to impute missing
values at the same time, which saves lots of additional efforts.
However, as we stated before, there are also some static features available in EHR data, which may have a role in the prediction of problematic
opioid use, such as history of substance use disorder and age at admission
(Amin-Esmaeili et al., 2016; Saha et al., 2016; Edlund et al., 2007).

Recurrent

Neural Networks (RNN) are beneficial in applications that strongly rely on timevariant variables but may be not capable of taking both static and temporal features as inputs. Most previous studies used RNN models as a feature extractor for temporal features. Activation values of hidden states of the RNN cells
are then concatenated with static features as a new set of features that is further fed into a discriminative machine learning model to make the final prediction
(Esteban et al., 2016; Leontjeva and Kuzovkin, 2016; Hsu et al., 2019). It is also
possible to tackle static feature by transforming them into “fake” sequences that
can be fed into RNN models. However, there is a risk of increased loss or decreased
accuracy per training time. Considering the structure of GRU-D, if we only include
static features in the last step, the missing data imputation will be only based on
the temporal feature itself, without considering the inter-correlation between temporal and static features. In EHR, the missingness of historical records may be
related to some baseline static features. For instance, a blood urea nitrogen (BUN)
test is more like to be conducted if the patient is admitted for a kidney failure or
has a history of kidney damage or other chronic condition such as diabetes or
high blood pressure. Therefore, by including static information into the GRU-D’s
learning process, it may be able to increase prediction accuracy while missing data
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and irregular time intervals are present in the data.
Our goal with this work is to predict opioid dependence and abuse during patients’ hospital visits using both static and temporal features. Our predictions are
based on patient’s medical history, the sequence of lab test results, the sequence of
medications prescribed for the patient, the sequence of input and output charts,
as well as patients’ admission information, which includes but is not limited to patients’ age, insurance type, and race. We proposed to build a conditional GRU-D
model to embed static features into the initial hidden state as condition variables
and evaluate the classification performance of conditional GRU-D model by comparing it with a GRU-D model with only temporal features. In addition, we would
like to investigate the feature importance in the best prediction model using Leave
One Feature Out (LOFO) Importance technique to detect significant risk factors
for opioid dependence and abuse.
3.2 Methodology
3.2.1 Data source and preprocessing
The current study used the Medical Information Mart for Intensive Care
III (Mimic-III)(Johnson et al., 2016) provided by the Massachusetts Institute of
Technology. This dataset integrates de-identified, comprehensive clinical data of
patients admitted to the critical care units of the Beth Israel Deaconess Medical Center in Massachusetts between 2001 and 2012. It includes the information
about bedside monitoring, laboratory tests, billing, demographics, diagnoses, and
procedures of 58,976 admissions from 48,520 distinct adult patients, with 1190
adult patients having opioid use disorder (OUD) related diagnosis. As the majortity of patients only present a single admission, we selected patients who were
older than 15 years, had only one admission and stayed in critical care units for at
least 48 hours. In order to identify our prediction target – the incidence of OUD,
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we used ICD-9 diagnosis codes associated with dependence and abuse of opioids,
including 304.00–304.03 (Opioid type dependence), 304.70–304.73 (Combinations
of opioids with any other), 305.50–305.53 (Nondependent opioid abuse), 965.0
(Poisoning; Opiates and Related Narcotics), 965.00 (Poisoning; Opium/alkaloids,
unspecified), 965.01 (Poisoning; Heroin), 965.02 (Poisoning; Methadone), 965.09
(Poisoning; Other opiates and related narcotics), E85.00 (Accidental Poisoning;
Heroin), E85.01 (Accidental Poisoning; Methadone), 97.01 (Poisoning; Opiate antagonists) and E85.02 (Accidental Poisoning; Other Opiates and Related Narcotics) (Heslin et al., 2015). The final dataset included 4534 patients.
Predictors used in our models include 5 categories: personal demographic
information (age at admission, race, insurance type etc.), disease history (a set of
binary variables, such as history of alcohol use disorder), medication prescriptions
during the stay, lab test results, and inputs and outputs records for the patients.
From medication prescriptions, we selected 27 drugs that were prescribed most
often. For lab test results, inputs, and outputs charts, we selected the top 20 items
with most occurrence from each. Therefore, we included 87 temporal predictors
in our models. All continuous features were standardized and values that are
4 standard deviation away from the mean and abnormal values were treated as
outliers and removed. Categorical features were dummy coded into several binary
features so we included 26 static predictors in our models.
3.2.2

Gated Recurrent Unit-D Model

Recurrent Neural Network (RNN) is a type of DL models for analyzing temporal data (Goller and Kuchler, 1996). RNN models perform the same action at
each time step of the sequence input and feed the output as part of the input
to the next time step, which enables RNN to memorize and update parameters
through all time steps. Among RNN models, Long Short-Term Memory (LSTM)
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and Gated Recurrent Unit (GRU) are most widely used. GRU was first introduced
by Cho et al. in order to make each recurrent unit to adaptively capture dependencies of different time scales (Cho et al., 2014). GRU can be implemented as
follow (Chung et al., 2014):
U pdate state : zt = σ(Wz xt + Uz ht−1 + bz )

(3.1)

Reset gate : rt = σ(Wr xt + Ur ht−1 + br )

(3.2)

Hidden state : activation : ht = (1 − zt ) ⊙ ht−1 + zt ⊙ h̃t ;

(3.3)

candidate activation : h̃t = tanh(W xt + U (rt ⊙ ht−1 ) + b),

(3.4)

where t is the time step, σ is the logistic sigmoid function, and ⊙ represents
element-wise product. As shown in Figure 3, at each time step t, GRU has a reset
gate rt and an update gate zt for each of the hidden state ht , which is treated
as the output of the input xt . Then, we smooth ht at every time step and apply
another sigmoid layer over them to make the prediction y.
GRU have been shown to achieve state-of-art performance for handling temporal data. However, in EHR data, most intervals between two measurements are
not evenly spaced, and measurements are not collected simultaneously and may
not have the same length. These irregular sampled data cannot be modeled effectively by GRU (Bang et al., 2020; Neil et al., 2016; Che et al., 2018). Thus, Che
et al. proposed GRU-D, which adds decay rates γt = exp{−max(0, Wγ δt + bγ )} to
standard GRU to model the decay mechanism of inputs and hidden output states
(Che et al., 2018). δt is a matrix of the time interval between two observations.
Missing observations will be imputed with x̂dt = mdt xdt +(1−mdt )(γxdt xdt′ +(1−γxdt )x̃d ).
mdt is a masking variable, which is 0 when the current observation is missing, 1 if
observed. The author used GRU-D in two health care applications of mortality
prediction and found GRU-D outperformed basic GRU models.
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Figure 3.1. Illustration of GRU model
3.2.3

Combining static and temporal features

As discussed before, EHR data contain both temporal information and static
information. Some static variables, such as age at admission, gender, race, and
disease history, are significantly associated with problematic opioid use. Some
previous studies suggest being male is a positive predictor for opioid misuse
and abuse (Edlund et al., 2007; Ives et al., 2006). Younger age is also supported
to be a significant predictor for opioid misuse (Webster, 2017; Turk et al., 2008;
Ives et al., 2006; Edlund et al., 2007). In addition, a personal history of non-opioid
substance abuse was found to be one of the most consistent predictors for opioid
misuse among chronic pain patients (Turk et al., 2008).
Therefore, we build a GRU-D model that can include both static features
and temporal features in OUD prediction. The first and simplest approach is to
include all static features at the first time step so that these features can influence
the hidden state of the GRU-D model. But RNN models are not able memorize
data for long time and may forget its previous inputs, especially input at first time
step. So this approach may be not able to model the influence of static features
when the sequence of temporal features are long.
Van den Oord et al. introduced a conditional Pixel convolutional neural network (CNN) to condition PixelCNN models for images on any vector,including
descriptive labels or tags, or latent embeddings created by other networks
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(Van den Oord et al., 2016). Their experiments show that with additional condition vectors, conditional PixelCNN can generate more realistic looking images
than the original PixelCNN. Based on this idea, we propose a conditional GRUD model that can condition temporal features on static features. In conditional
GRU-D model, static features are treated as condition variables x to initiate the
hidden state of the GRU-D. We follow the steps described as below:
1. For each training sample, take static features as a condition variable vector
⃗x
2. Transform condition variable vector ⃗x with an affine transformation to get it
into the same shape as the hidden state of the RNN, ⃗v = W ⃗x+⃗b, where W and
⃗b are trainable weights. This step is achieved using a linear transformation
in Pytorch (Paszke et al., 2019).
3. In the initial step, add ⃗v to the hidden state of the GRU-D when computing
its value.
Follow these step, GRU-D model with temporal inputs can be properly conditioned
on static inputs.
3.2.4

Model Development and Evaluation

We also considered a GRU-D model with only temporal features as the baseline model, as well as a GRU-D model with all static features included at the
first time step. The models were implemented in Pythonpython using Pytorch
(Paszke et al., 2019).
We randomly split the data into three subsets: training set, validation set,
and test set. The training set included 60% of the patients, 20% were included in
the validation set, and another 20% of the patients were assigned to the test set.
Different experiments were performed to compare the performance of three models,
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with different sets of hyperparameters, such as learning rate and number of hidden
units. For optimization, we chose the Adam algorithm (Kingma and Ba, 2014) to
update the weights since it is currently recommended as the default gradient descent optimization algorithm to use (Ruder, 2016). Binary Cross Entropy between
the target and the input probabilities was used to estimate the prediction loss. We
repeated each experiment five times with different random splits of the data.
The performance of the models was evaluated and compared using the mean
area under the Precision-Recall curve (AUPRC), mean area under Receiver Operating Characteristics curve (AUROC), and F1-score. Since the target group we
want to predict – OUD patients only accounts for a small portion of the total sample, we focused more on detecting when an opioid abuse or dependence is going to
happen rather than when it is not going to happen. We would like to get a high
sensitivity value (true positive rate) and focus less on specificity (true negative
rate). Precision is the percentage of correct positive predictions relative to total
positive predictions, and recall is the percentage of correct positive predictions
relative to total actual positives. Precision-recall (PR) curves plot the positive
predictions against the true positive rate, and F1-score is a weighted harmonic
mean of precision and recall. Thus, PR curves and F1-score are a better metrics
to evaluate the prediction performance when the target event happens much less
frequently.
3.2.5

Feature Importance

GRU-D models, like other neural networks, are black box models that aim for
predictive accuracy rather than for inference. It’s hard to understand the role of
each predictor in the prediction model. Leave-One-Covariate-Out (LOCO) technique was proposed by Lei et al. (Lei et al., 2018). This approach compares the
performance of a whole model with the performance of a model which is fitted with
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a subset of the features. We implemented this technique using Pytorch following
the steps below:
1. Train an original model and estimate a baseline model loss loss0 , such as
binary cross entropy loss in this study
2. For each feature j = 1, . . . , p, remove feature j from the data X and refit
model with data X−j
3. Estimate loss based on the predictions of the reduced data X−j and Calculate
LOCO Feature Importance F Ij = loss−j − loss0
3.3 Results
3.3.1 Descriptive statistics and missingness
Among 4534 patients aged 16 to 107 years in the study sample, 15.04%
(n = 682) had opioid dependence or abuse related diagnosis. Their demographic
collected at admission are reported in Table 6. Most of the patients were white
(70.58%) and admitted from emergency department (86.35%). There were more
patients with a history of hypersensitivity lung disease than those with a history
of anxiety disorder or alcohol use disorder. More than half of the patients were
covered by Medicare (55.56%).
In the dataset, both the irregular sampling issue and the asynchronism of
feature sampling problem were observed. The 87 temporal features were collected
at varying frequency across the data. Some variables, such as blood test results,
were measured far more often than others, whilst others were measured seldom.
We picked a feature at random from the medication prescriptions, lab test results,
and inputs and outputs records. As shown in Figure 4, urine void from the output
charts and the morphine sulfate drug had around 550 counts while chloride blood
test had more than 3,500 records. The use of the GRU-D model was encouraged
to address this problem to predict OUD with temporal features from EHR data.
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Figure 3.2. Histogram for randomly selected three features
3.3.2

Model Performance

Three models were trained and validated on 5 different sets of training and
validation sets. Table 7 shows the performance results of three models in predicting
opioid dependence or abuse in the test sets, including AUROC, AUPRC, and F1score. In terms of AUROC, the GRU-D model which included static features at
the first time step was the best-performed model (0.793) followed by conditional
GRU-D model (0.676), and GRU-D with temporal features only (0.658). All three
models’ AUROCs are higher than 0.5, which means the predictions made by the
models are better than a random guess. Same findings can also be observed from
Figure 5. The ROC for GRU-D with static features added at the first step is farther
away from the no-skill diagonal toward the upper-left corner than the curves for
the other two models. Based on AUPRC, GRU-D with static features added at
the first time step still has the best performance with much a larger mean AUPRC
value than the other two models. The conditional GRU-D’s AUPRC is slightly
larger than the one for GRU-D with only temporal features. Figure 6 shows that
the curve for GRU-D with static features added at the first time step bows more
towards (1,1) above the flat x-axis of no skill than those of conditional GRU-D
and GRU-D with only temporal features. F1-scores also show a similar pattern,
with GRU-D with static features added at the first time step the best-performed
model (0.38).
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Overall, the GRU-D with static features added at the first time step has the
best prediction performance. In addition, based on recall scores, out of all the
patients that actually did get an opioid dependence or abuse related diagnosis,
this model predicted this outcome correctly for 29% of those patients. Based on
precision score, 53% of all the patients that the model predicted would get an
opioid dependence or abuse related diagnosis actually got opioid dependence or
abuse related diagnosis.

Figure 3.3. Model performance based on the area under the receiver operating
characteristic curve(AUROC)

3.3.3

Risk factors based on feature importance

We evaluated the importance of 113 features in the best-performed model,
GRU-D model with static features added at first time step, using Leave-OneCovariate-Out (LOCO) technique. We selected the top 15 features that have the
highest feature importance scores and plotted their average loss against the baseline
loss in Figure 7. The distance from the baseline loss line to the right edge of the
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Figure 3.4. Model performance based on the area under the precision-recall
curve(AUPRC)
bar indicates the LOCO feature importance.
Glucose blood test result was ranked to be the most important predictor for
opioid dependence or abuse. Among the 15 most important features, 4 are static
features, including being a Native American, being widowed, having a history
of anxiety disorder, and being covered by Medicare. Medications, like magnesium
sulfate drug, Lactated Ringer’s injection, ondansetron drug, morphine sulfate, also
play a role in the prediction of opioid use disorder.
3.4

Discussion
This study yield valuable insights because of the use of RNN to develop a

prediction model for opioid dependence and abuse based on static and temporal features from the EHR simultaneously. Many machine learning studies that
predict opioid-related risks ignore the temporal structure within the EHR data
(Ellis et al., 2019; Karhade et al., 2019b; Dong et al., 2019). As a result of the
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growth of deep learning (DL) models, an increasing number of research papers
are employing DL with EHR data to forecast a range of health-related risks in
a long term, including in-hospital mortality, diagnoses classification, and length
of stay (Lipton et al., 2015; Rajkomar et al., 2018; Bang et al., 2020). However,
few studies have used DL models in opioid related predictions or combined static
features in the prediction. In the current study, we built and compared several
predcition models based on GRU that not only can handle irregular sampling issue but also are capable of combining both static and temporal variables from
EHR data, in order to solve the task of predicting opioid dependence or abuse
among patients in critical care units. The comparison of model performance suggests adding static features as condition variables can slightly improve prediction
performance of the GRU-D model only based on temporal features. Our findings
indicate that simply integrating static features at the first time step in the GRU-D
model may result in a reasonably good prediction, even better than the prediction
made by conditional GRU-D model. We hypothesize that this may be due to the
insufficient size of the sample used in this study. Therefore, the best-performed
model has 27 more features than the conditional GRU-D model due to the addition
of 27 static features at the first time step.
In addition, we investigated the feature importance in the best-performed
model using LOCO approach and the results show that static features, including, being a Native American, being widowed, having a history of anxiety disorder, and being covered by Medicare are important factors to predict opioid
dependence or abuse. Anxiety disorder or mood disorder has been widely recognized as a significant risk factor of OUD (Martins et al., 2012; Vorspan et al., 2015;
Blanco et al., 2013; Martel et al., 2013; Fischer et al., 2012). Martins et al. conducted a national longitudinal study using 34,653 adults’ surveys from the Na-

60
tional Epidemiologic Survey on Alcohol and Related Conditions and found that
baseline mood disorders were significantly associated with incident opioid disorder
due to prescription opioid use at follow-up (Martins et al., 2012). Vorspan et al.
conducted a literature review on the association of any substance use disorders
and anxiety (Vorspan et al., 2015). Among different kinds of substance use disorder, anxiety disorders or anxiety symptoms are constantly found significant in
multiple studies that investigated factors associated with prescription opioid dependence (Blanco et al., 2013; Martel et al., 2013; Fischer et al., 2012). Another
notable predictor of opioid use disorder is insurance type. Medicare is the federal
health insurance program for people aged 65 and older, certain younger people with
disabilities and people with End-Stage Renal Disease. So being covered by Medicare may indicate that this patient is older than 65 years old, or having certain disability or severe renal disease. Younger age is supported to be a significant predictor for opioid misuse in lots of previous studies (Webster, 2017; Turk et al., 2008;
Ives et al., 2006; Edlund et al., 2007). In term of renal disease, chronic pain is
a common symptom among patients with end-stage renal disease and there is
a high use of opioid among this population (Roy et al., 2020). Thus, they may
be esposed to higher risk of opioid dependence. In addition to static predictors,
temporal predictor, glucose blood test result is identified as the most important
predictor in our GRU-D model. Glucose test is more likely to be prescribed to patients with diabetes, and opioids are often prescribed to manage diabetes-related
neuropathic pain (Jensen et al., 2006). Long-term use of opioids may lead to opioid misuse and abuse (Walter et al., 2017). In addition, evidence from pre-clinical
and clinical studies suggest that opioid use is associated with glucose dysregulation, which may let the patient need a glucose test (Mysels and Sullivan, 2010).
Among all the drug related important features, besides morphine sulfate, mag-
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nesium sulfate drug and ondansetron drug are also found associated with opioid dependence and abuse. A clinical study demonstrates that magnesium may
reduce the severity of opioid addiction and significantly relieve withdrawal syndrome symptoms (Nechifor et al., 2004). Moreover, according to a prior research,
treatment with the 5-HT3 receptor antagonist (5-HT3-RA) ondansetron may decrease objective measurement of Opioid withdrawal (OW) in adults by up to 76%
(Chu et al., 2009). The intensity of OW symptoms is a primary factor in the risk
for dependence to prescribed and illicit opioids. Ondansetron was also found to be
able to decrease alcohol consumption and cravings in patients with alcohol use disorder (Kranzler et al., 2003). Hence, ondansetron drug’s effect on opioid addition
is worth continuing to investigate.
This study has limitations. First, to combine static and temporal features, we
modified the structure of GRU-D model, or just added static features at the first
time step. But the results suggest that the performance of our proposed conditional
GRU-D model performed was not as good as the simple GRU-D model. Secondly,
GRU-D model, like most neural networks, is a black-box model. Even though we
estimated the importance of features in the prediction using LOCO approach, we
cannot know whether this feature is a protective factor that is associated with a
lower likelihood of opioid dependence and abuse, or a risk factor that is associated
with a higher likelihood of our target events. Thirdly, this study only consists of
around 4,000 patients. To develop a practical decision support model, we need to
include as much patients as possible to make reliable predictions for future events.
For next steps, we first would like to develop an ensembled GRU-D model.
Recently, there are studies exploring how to handle both static and temporal features using ensembled RNN model (Esteban et al., 2016). In the ensembled RNN
model, RNN is used as a temporal feature extractor, and the activations of the last
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neural net work layer at the last iteration are combined with the static features as
a new set of features. Then a traditional machine learning model, such as random
forest (RF) model, can be trained on this new set of features to make predictions.
Second, to investigate whether a feature is a protective or risk factor, there are
several methods we can utilize in the future. For example, we can transform the
values of a feature to negative values to fit the model and then set the values
to positive values to fit the model again. So we can investigate how the average
effect of this feature on target variable changes. Another approach is to split the
whole sample to subgroups based on certain feature in order to compare the effect of this feature on target variable in different subgroups. Lastly, we plan to
integrate more data into our model to improve the performance of our prediction
for opioid dependence and abuse. In addition, due to the limited sample size, we
only included temporal features from medication prescription, lab test results, and
input and output charts. With a larger sample size, we may be able to incorporate
more information from EHR data, such as vital signs like heart rate. Last but
not least, since more than 70% of the patients in this study are white patients,
the fairness of this prediction model needs further investigation. This topic has
been increasingly discussed in Artificial Intelligence (AI) applications, especially
in some sensitive areas, such as health care and criminal justice. AI models are
driven by data. Hence, when a model is trained on a data set, where a minority
group is not sufficiently represented, the results produced may be misleading and
the algorithm may be unfair (Veale and Binns, 2017). Hence, a prediction model
based on a more diverse group will be developed in the future.
3.5

Conclusion
This study demonstrates the feasibility and potential of GRU-D models to

predict opioid dependence and abuse using static and temporal information from
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EHR data. Conditional GRU-D model and GRU-D model with static features
added at first time step can produce a better prediction than the model only based
on temporal features. Especially, the GRU-D model with static features added at
first time step has fairly good prediction performance and appear to be a valuable
tool to identify patients at high risk of opioid dependence and abuse. This study
also investigated and revealed the importance of several features from laboratory
tests and medication prescriptions in the prediction of problematic opioid use.
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Table 3.1. Demographic characteristics
Feature
% or Mean (SD)
Age at Admission
70.58 (50.43)
Admission Type
Elective
11.84
Emergency
86.35
Urgent
1.81
Insurance Type
Government
3.13
Medicaid
14.20
Medicare
55.56
Private
26.29
Self pay
0.82
Marital Status
Divorced
7.96
Life partner
0.04
Married
43.91
Separated
1.21
Single
30.68
Widowed
12.55
Unknown
0.49
Race
White
70.58
Black or African American
13.98
Asian
2.25
Native American
0.15
Unknown/not specified
12.73
Anxiety Disorder
Yes
3.11
No
96.89
Alcohol Use Disorder
Yes
2.30
No
97.70
Hypersensitivity Lung Disease
Yes
15.01
No
85.00

N
4534
537
3915
82
142
644
2519
1192
37
361
2
1991
55
1391
569
22
3200
634
102
7
591
141
4393
104
4430
680
3854
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Table 3.2. Model performance based on mean AUROC, AUPRC, and F1-score
AUROC AUPRC F1-Score
Conditional GRU-D
0.676
0.281
0.09
GRU-D
0.793
0.417
0.38
with static added at 1st time step
GRU-D
0.658
0.273
0.06
with temporal only
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Figure 3.5. Importance of the features in the best-performed model (GRU-D model
with static added at first time step) based on LOCO
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APPENDIX
Code for shared parameter model in Manuscript 2
A.1 R code for shared parameter joint model in JAGS
model_string <-"
model{
for (i in 1:n ){
# Longitudinal submodel
for ( j in 1 :M[i]){
Yij[i,j] ~ dnorm(mu[i,j],tau)
mu[i,j] <- inprod(betaL[], XL[i,j, ]) + inprod(b[i,],ZL[i,j, ])
}
# Hazard function
for( j in 1:K){
haz[i,j] <- lambda*pow(Time[i]/2 * (xk[j]+1), lambda - 1)*
exp(inprod(betaS[], XS[i,])+
alpha*(b[i,1] + b[i,2] *(Time[i]/ 2*(xk[j] + 1 ))))
}
# Log-survival function with Gauss-Legendre quadrature
logSurv[i] <- -Time [i]/2 * inprod(wk,haz[i ,])
# survival log-likelihood using zero tricks
phi[i] <- 100000 - death[i] * log(haz[i,K]) - logSurv[i]
zeros[i] ~ dpois(phi[i])
# Random effects
b[i,1:Nb] ~ dmnorm(mub[],Omega[ ,])
}
# Priors
for(l in 1:NbetasS){ betaS[l] ~ dnorm(0.0, 0.001)}
alpha ~ dnorm(0.0, 0.001)
lambda ~ dunif(0, 10)
for(l in 1:NbetasL){ betaL[ l ] ~ dnorm(0.0, 0.001)}
tau <- pow(sigma , -2)
sigma~ dunif(0, 100)
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Omega[1:Nb,1:Nb] ~ dwish(V[ ,],Nb)
Sigma[1:Nb,1:Nb] <- inverse(Omega[ ,])
# Derived quantity
q <- exp(betaS[1])
}
"
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APPENDIX
Simulation for shared parameter model with missing time-varying
covariates in Manuscript 2
B.1

Simulation
The performance of the shared parameter joint model regarding the percent-

age of missing values is evaluated using 100 simulated datasets with each having
N = 100 individuals. For simplicity, we include one binary time-independent
covariate x1i , one continuous time-independent covariate x2i in time-to-event submodel, and 1 time-varying longitudinal variable yi (t). Three scenarios with different percentage of missing were considered, including no missing, 20% missing and
40% missing. And the missing values in yi (t) were assumed MAR, which means the
probability of missing depends on obeserved time-independent covariates x1i and
x2i . The complete datasets were simulated using simjm package (Brilleman, 2018)
following the forms below:

yi (t) = β00 + b0i + (β10 + b1i )t + ϵi (t)
hi (t) = λtλ−1 exp(γ0 + γ1 x1i + γ2 x2i + α(b0i + b1i )t),
where β00 = 2, β10 = −0.5, γ0 = −3.3, γ1 = −0.5, γ2 = 0.5, and α = 0.5. The
binary covariate x1i was simulated from Bern(0.5) and the continuous covariate
x2i was generated from a normal distribution N (0, 1). The random effects (b0i , b1i )′
satify a normal distribution with mean of 0 and variance of Σ. The variancecovariance matrix, Σ, can be represented as Σ = V RV , where R is the correlation
matrix and V = diag(σb ) is a square diagonal matrix with the standard deviations


1 0.5
as the diagonal elements. We consider σb = (2, 1) and R =
. The R code
0.5 1
is included in Appendix A.
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Each simulated dataset were then processed to create two more datasets with
20% or 40% missing values in yi (t). We fit the shared parameter joint model for
each simulated dataset using 3 chains of 10,000 MCMC iterations, which included
5,000 burn-in iterations that were not used for inference.
B.2

R code for simulating longitudinal and time-to-event data using
simjm function
dat <- simjm(n = n, M = 1, fixed_trajectory = "linear",
random_trajectory = "linear",
assoc = "shared_b(1)",
basehaz = c("weibull"),
betaLong_intercept = 2,
betaLong_binary = 0,
betaLong_continuous = 0,
b_sd=c(2,1),b_rho=0.5,
betaLong_linear = -0.5,
betaEvent_intercept = -3.3,
betaEvent_binary = -0.5,
betaEvent_continuous = 0.5,
betaEvent_assoc = 0.5,
max_yobs = 10,
max_fuptime = 10, balanced = TRUE,family = gaussian)
B.3

Simulation Results
To compare the model performance under different missing percentages, we

calculated and reported the following estimates using 100 simulated datasets:
• the mean of the posterior distribution for each parameter
• the mean standard deviation (SD) of the posterior distribution for each parameter
• the standard error (SE) of the posterior mean for each parameter, defined as
the standard deviation of the estimates
• the 95% credible interval of the posterior distribution form each parameter.
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Table B.1. Parameter
Mean SD
γ0 -3.486 0.439
γ1 -0.679 0.301
γ2 0.666 0.172
α
0.001 0.021
β00 2.022 0.193
β10 -0.492 0.099

estimates for complete dataset
SE
Lower CI Upper CI
0.927 -4.352
-2.638
0.818 -1.269
-0.089
0.459 0.330
1.005
0.020 -0.040
0.042
0.207 1.645
2.396
0.110 -0.681
-0.305

Table B.2. Parameter estimates for dataset with 20%
Mean SD
SE
Lower CI
γ0 -3.492 0.440 0.929 -4.360
γ1 -0.679 0.302 0.821 -1.270
γ2 0.669 0.173 0.463 0.332
α
-0.002 0.031 0.027 -0.061
β00 1.299 0.197 0.180 0.911
β10 -0.788 0.105 0.118 -0.987

missing values (MNAR)
Upper CI
-2.642
-0.088
1.011
0.059
1.684
-0.587

From Table 2.1 - 2.3, we observe the estimates for intercept and covariates’
coefficients in time-to-event submodel are similar across three scenarios. As the
missing percentage increases, the difference between true value and estimated value
increases slightly, and so do the SD and SE. However, the posterior mean for
association parameter α are close 0, differing significantly from the true value. In
addition, there is a large difference between the 3 posterior means. We suspect
this may be related to the estimates of intercept and slope in the longitudinal
submodel. Because the posterior mean for fixed-effect intercept and slope gets far
from the true value when the missing percentage increases.
The simulation results didn’t meet our expectations, especially for the estimates of association parameters. We suspect this might be related to the R package
we used to simulate joint longitudinal and time-to-event data. Although the author
of this package showed simjm function can simulate distributions close to the target
distribution (Brilleman, 2018), the whole simulation process is not transparent. We
should consider using a different package, such as simsurv (Brilleman et al., 2020),
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Table B.3. Parameter estimates for dataset with 40%
Mean SD
SE
Lower CI
γ0 -3.494 0.440 0.938 -4.361
γ1 -0.682 0.303 0.825 -1.278
γ2 0.670 0.174 0.464 0.332
α
0.003 0.034 0.031 -0.064
β00 1.048 0.212 0.199 0.635
β10 -0.869 0.107 0.123 -1.073

missing values (MNAR)
Upper CI
-2.644
-0.091
1.012
0.070
1.465
-0.659

or simulating data from sketch to make sure all the parameters are speficied correctly.
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